Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Jun ‘18 |
|
|---|---|---|---|---|---|
| $3.52M | $12.3M | $8.78M | 30.9% |
|
|
| $3.51M | $11.2M | $7.71M | 19.2% |
|
|
| $3.48M | $4.87M | $1.39M | 96.2% |
|
|
629
Idexx Laboratories
IDXX
$51B
| $3.46M | $46.6M | $43.2M | 192% |
|
| $3.46M | $6.24M | $2.78M | 97% |
|
|
| $3.46M | $3.9M | $443K | 33.5% |
|
|
| $3.45M | $3.75M | $297K | 57.3% |
|
|
| $3.43M | $3.77M | $345K | 41.1% |
|
|
| $3.42M | $3.64M | $218K | 97.2% |
|
|
| $3.39M | $25.2M | $21.8M | 81% |
|
|
636
iShares US Pharmaceuticals ETF
IHE
$596M
| $3.35M | $4.53M | $1.18M | 45.9% |
|
| $3.31M | $3.31M | $0 | 34% |
|
|
| $3.3M | $5.05M | $1.75M | 185% |
|
|
| $3.29M | $8.2M | $4.91M | 8.94% |
|
|
| $3.29M | $3.43M | $147K | 47.6% |
|
|
| $3.29M | $4.66M | $1.37M | 61.4% |
|
|
| $3.27M | $7.21M | $3.94M | 99.7% |
|
|
| $3.24M | $4.46M | $1.22M | 27.8% |
|
|
| $3.24M | $7.65M | $4.42M | 30% |
|
|
| $3.17M | $5.03M | $1.86M | 173% |
|
|
| $3.14M | $9.92M | $6.78M | 30.6% |
|
|
| $3.13M | $24.7M | $21.6M | 97.9% |
|
|
| $3.09M | $3.35M | $257K | 26.4% |
|
|
| $3.06M | $4.03M | $966K | 39.4% |
|
|
| $3.06M | $3.23M | $175K | 12% |
|